ArticleTropical animal health and production2026
Comparative evaluation of oxytetracycline and an herbal formulation in the treatment of bovine anaplasmosis.
Article in Tropical animal health and production, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study evaluated and compared the therapeutic efficacy of oxytetracycline and a standardized polyherbal formulation in cattle naturally infected with Anaplasma marginale. A total of 30 cattle were screened, of which 20 animals confirmed positive by Giemsa-stained blood smear and polymerase chain reaction (PCR) were randomly allocated into two treatment groups: Group I received oxytetracycline (10 mg/kg body weight, intravenously for five days), while Group II received a polyherbal medicinal powder (5 g/animal/day orally for ten days), both along with supportive therapy. Ten apparently healthy cattle were used as controls. Clinically affected cattle exhibited fever, anorexia, anemia, lethargy, tachycardia, tachypnea, and tick infestation. Haematological analysis revealed significantly reduced haemoglobin (6.20 ± 0.27 g/dL), packed cell volume (23.15 ± 1.28%), and total erythrocyte count (5.80 ± 0.44 × 10⁶/µL), along with increased total leukocyte count (8.49 ± 0.50 × 10³/µL), lymphocytes (64.9 ± 2.48%), and reduced platelet count (252.5 ± 79.85 × 10³/µL), along with leucocytosis and lymphocytosis in infected animals. Following treatment, both groups showed improvements in clinical signs and haematological parameters. However, oxytetracycline resulted in a 70% clinical recovery rate, with three fatalities and persistent PCR positivity in recovered animals. In contrast, the herbal formulation achieved complete clinical recovery with no mortality, significant improvement in platelet counts, and absence of PCR-detectable infection during the 14-day follow-up period. These findings suggest that the evaluated polyherbal formulation may offer a safe, economical, and practical therapeutic alternative for bovine anaplasmosis, particularly in resource-limited settings. Larger controlled trials with extended follow-ups are warranted to validate these preliminary observations.
Indexed as
Identifiers
41706257What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.